Browse Drug Recalls
6 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 6 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 6 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jun 4, 2018 | Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Si... | Presence of Particulate Matter; Potential for particulate matter on the syringe plunger. | Class I | HOSPIRA INC, LAKE FOREST |
| Jul 26, 2017 | Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Singl... | Presence of Particulate Matter: Silicone oil | Class II | HOSPIRA INC, LAKE FOREST |
| Jul 26, 2017 | Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Si... | Presence of Particulate Matter: Silicone oil | Class II | HOSPIRA INC, LAKE FOREST |
| Jul 26, 2017 | Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Si... | Presence of Particulate Matter: Silicone oil | Class II | HOSPIRA INC, LAKE FOREST |
| Mar 18, 2016 | 8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL),... | Presence of Particulate Matter: particulate matter identified as an insect in one vial. | Class I | Hospira Inc. |
| Jan 9, 2014 | Aminosyn 3.5% M Sulfite-Free, A Crystalline Amino Acid Solution* with Mainten... | Lack of Assurance of Sterility; potential leakage from administrative port. | Class II | Hospira Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.